Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2018

Nov 13, 2018

33899_dirs_2018-11-13_868a144b-3450-4740-9d0b-f4d4c530a0b0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2018-11-07

Reporting Person: ROBINSON TIMOTHY G (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-07 Common Stock M 2500 $44.73 Acquired 27208 Direct
2018-11-07 Common Stock F 1437 $153.31 Disposed 25771 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-07 Stock Options $44.73 M 2500 Disposed 2027-02-16 Common Stock (2500) Direct

Footnotes

F1: These options vest in three equal annual installments beginning 2/16/2018